Table 2 Characteristics of the prescribed medication of the 165 study participants at baseline
Variable | Number (%) | |||
|---|---|---|---|---|
All (n = 165) | Asthma (n = 50) | COPD (n = 89) | ACO (n = 26) | |
Medication (n = 326) | ||||
LABA/ LAMA combinations | 21 (6.4) | 1 (0.3) | 16 (4.9) | 4 (1.2) |
LABA/ICS combinations | 116 (35.5) | 44 (13.5) | 50 (15.3) | 22 (6.7) |
LAMA | 75 (23) | 5 (1.5) | 60 (18.4) | 10 (3.1) |
LABA | 23 (7) | 3 (0.9)a | 15 (4.6) | 5 (1.5) |
ICS | 17 (5.2) | 8 (2.5) | 4 (1.2) | 5 (1.5) |
SAMA | 2 (0.6) | 1 (0.3) | 1 (0.3) | 0 (0) |
SABA | 68 (20.9) | 28 (8.6) | 31 (9.5) | 9 (2.8) |
SABA/SAMA combinations | 4 (1.2) | 0 (0) | 1 (0.3) | 3 (0.9) |
Number of inhaled medication at baseline | ||||
1 | 50 (30.3) | 17 (34) | 27 (30.3) | 6 (23.1) |
2 | 71 (43) | 26 (52) | 37 (41.6) | 8 (30.8) |
3 | 42 (25.5) | 7 (14) | 23 (25.8) | 12 (46.2) |
4 | 2 (1.2) | 0 (0) | 2 (2.2) | 0 (0) |